• Citer

A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.

par Mestre, Leyre;Docagne, Fabian;Correa, Fernando;Loría, Frida;Hernangomez Herrero, Miriam ;Borrell, J.;Guaza, Carmen
Référence Molecular and cellular neurosciences, 40, 2, page (258-266)
Publication Publié, 2009-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules.
Auteur:	Mestre, Leyre; Docagne, Fabian; Correa, Fernando; Loría, Frida; Hernangomez Herrero, Miriam; Borrell, J.; Guaza, Carmen
Informations sur la publication:	Molecular and cellular neurosciences, 40, 2, page (258-266)
Statut de publication:	Publié, 2009-02
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Animals
	Behavior, Animal -- physiology
	Benzoxazines -- pharmacology
	Calcium Channel Blockers -- pharmacology
	Cannabinoids -- agonists -- pharmacology -- therapeutic use
	Cardiovirus Infections -- physiopathology
	Disease Models, Animal
	Disease Progression
	Endothelium -- cytology -- drug effects -- metabolism
	Female
	Humans
	Intercellular Adhesion Molecule-1 -- genetics -- metabolism
	Mice
	Morpholines -- pharmacology
	Motor Activity -- physiology
	Multiple Sclerosis -- drug therapy -- pathology -- physiopathology
	Naphthalenes -- pharmacology
	PPAR gamma -- metabolism
	Receptor, Cannabinoid, CB1 -- metabolism
	Receptor, Cannabinoid, CB2 -- metabolism
	Theilovirus -- metabolism
	Vascular Cell Adhesion Molecule-1 -- genetics -- metabolism
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
Langue:	Anglais
Identificateurs:	urn:issn:1044-7431
	info:doi/10.1016/j.mcn.2008.10.015
	info:pii/S1044-7431(08)00290-X
	info:pmid/19059482